Procter & Gamble (NYSE:PG) Given “Neutral” Rating at DA Davidson

DA Davidson reaffirmed their neutral rating on shares of Procter & Gamble (NYSE:PGFree Report) in a research report report published on Wednesday,Benzinga reports. They currently have a $160.00 price objective on the stock.

A number of other research analysts have also recently weighed in on PG. DZ Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a research note on Thursday, August 29th. Piper Sandler began coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price on the stock. Jefferies Financial Group cut shares of Procter & Gamble from a “buy” rating to a “hold” rating and lowered their target price for the company from $182.00 to $175.00 in a research note on Wednesday, July 24th. Morgan Stanley lifted their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $164.00 target price on shares of Procter & Gamble in a research note on Monday, October 21st. Nine investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average price target of $178.00.

Check Out Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Trading Up 2.0 %

NYSE:PG opened at $176.28 on Wednesday. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. Procter & Gamble has a 12 month low of $142.50 and a 12 month high of $177.94. The company has a market cap of $415.15 billion, a PE ratio of 30.39, a price-to-earnings-growth ratio of 3.74 and a beta of 0.42. The company has a 50 day simple moving average of $170.04 and a two-hundred day simple moving average of $168.64.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter in the previous year, the firm posted $1.83 EPS. The company’s revenue for the quarter was down .6% compared to the same quarter last year. Research analysts forecast that Procter & Gamble will post 6.94 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a $1.0065 dividend. The ex-dividend date of this dividend was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.28%. Procter & Gamble’s dividend payout ratio is currently 69.48%.

Insider Transactions at Procter & Gamble

In related news, insider Susan Street Whaley sold 634 shares of the stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the completion of the sale, the insider now owns 19,341 shares of the company’s stock, valued at $3,319,882.65. This represents a 3.17 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Andre Schulten sold 13,041 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the sale, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at $6,325,360. The trade was a 25.95 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 160,693 shares of company stock valued at $27,311,345. Company insiders own 0.18% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble in the second quarter worth $28,000. Fairway Wealth LLC acquired a new stake in shares of Procter & Gamble in the second quarter worth $29,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of Procter & Gamble in the third quarter worth $33,000. POM Investment Strategies LLC acquired a new stake in shares of Procter & Gamble in the second quarter worth $34,000. Finally, Quest Partners LLC acquired a new stake in shares of Procter & Gamble in the second quarter worth $36,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

See Also

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.